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Abstract
Background: WRN is a multi-functional protein involving DNA replication, recombination and repair. WRN acetylation has
been demonstrated playing an important role in response to DNA damage. We previously found that WRN acetylation can
regulate its enzymatic activities and nuclear distribution.
Methodology/Principal Finding: Here, we investigated the factors involved in WRN acetylation and found that CBP and
p300 are the only major acetyltransferases for WRN acetylation. We further identified 6 lysine residues in WRN that are
subject to acetylation. Interestingly, WRN acetylation can increase its protein stability. SIRT1-mediated deacetylation of WRN
reverses this effect. CBP dramatically increases the half-life of wild type WRN, while mutation of these 6 lysine residues
(WRN-6KR) abrogates this increase. We further found that WRN stability is regulated by the ubiquitination pathway and
WRN acetylation by CBP significantly reduces its ubiquitination. Importantly, we found that WRN is strongly acetylated and
stabilized in response to mitomycin C (MMC) treatment. H1299 cells stably expressing WRN-6KR, which mimics unacetylated
WRN, display significantly higher MMC sensitivity compared with the cells expressing wild-type WRN.
Conclusion/Significance: Taken together, these data demonstrate that WRN acetylation regulates its stability and has
significant implications regarding the role of acetylation on WRN function in response to DNA damage.
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Introduction
Mutations in the WRN gene cause Werner syndrome (WS), a
rare autosomal recessive disorder. WS is a cancer prone syndrome
and also displays premature aging [1]. In culture, WS cells
undergo replicative senescence much more rapidly than normal
cells do, and are also hyper-sensitive to several DNA damaging
agents [2–5]. In addition, WS cells show increased genomic
instability [6,7]. WRN is a 1432-amino-acid (160 kD) protein and
a member of human RECQ helicase family [8]. There are five
known members in this family, RecQ1, BLM, WRN, RecQ4 and
RecQ5. Mutations in BLM and RecQ4 also cause Bloom
Syndrome [9], and Rothmund Thomason syndrome [10],
respectively. Consistent with other family members, WRN protein
contains 39 to 59 helicase activity and DNA-dependent ATPase
activity. However, among the human RecQ family members,
WRN protein uniquely contains 39–59 exonuclease activity [11].
WRN appears to be a multi-functional component in various
processes, including DNA replication, recombination, repair, and
telomere maintenance, possibly through interacting with different
proteins [12].
Posttranslational modification can regulate protein-protein
interaction, modulate enzymatic activities, and influence cellular
localization and protein stability [13]. WRN can be acetylated in
response to various DNA damaging agents [14–17]. WRN
acetylation facilitates its translocation from nucleoli to nucleo-
plasm [14,16] and also regulates its enzymatic activities [16,17].
These findings indicate that WRN acetylation plays an important
role in the cellular response to DNA damage.
Acetylation can regulate the stability of various proteins.
Acetylation of the C-terminal domain of p53 is sufficient to
abrogate its ubiquitination and extend its half-life in vivo [18].
SREBPs were reported to be acetylated by CBP/p300, and
acetylation stabilizes members of the SREBP family of transcrip-
tion factors [19]. Acetylation of hepatocyte nuclear factor 6
(HNF6) results in increasing both HNF6 protein stability and its
ability to stimulate transcription of the glucose transporter 2
promoter [20]. Acetylation of b-catenin by PCAF can up-regulate
its abundance by inhibiting its ubiquitination and improving its
stability [21]. E2F1 can also be acetylated by PCAF, a
requirement to stabilize the protein in response to DNA damage
[22]. Acetylation of Smad7 by p300 can stabilize and protect it
from TGFb-induced degradation. The same lysines in Smad7
subject to acetylation are also targeted by ubiquitination.
Importantly, acetylation of Smad7 can prevent its ubiquitination
[23].
Recently, Kahyo and colleagues reported that sirtuin-mediated
deacetylation can stabilize WRN protein [24]. In order to further
PLoS ONE | www.plosone.org 1 April 2010 | Volume 5 | Issue 4 | e10341
understand the regulation of WRN acetylation and its stability, we
identified WRN acetylation sites and made a WRN mutant that
could not be acetylated to test its stability. We found that WRN
acetylation can increase its protein stability. Deacetylation of
WRN by SIRT1 can reverse this effect. CBP dramatically
increases the half-life of wild type WRN, while this increase is
abrogated with the WRN acetylation mutant. We further found
that WRN stability is regulated by the ubiquitination pathway,
and WRN acetylation by CBP can dramatically reduce its
ubiquitination. These findings advance our understanding on
WRN regulation in response to DNA damage.
Results
Identification of WRN acetylation sites
Different acetyltransferases may acetylate different sites of their
target proteins. In order to identify WRN acetylation sites, we first
screened several acetyltransferases associated with histone protein
acetylation including CBP/p300, PCAF, MOF, and Tip60 for
WRN acetylation. After co-transfection of FLAG-tagged WRN
with each of the acetyltransferases into HEK293 cells, WRN
protein was immunoprecipitated and its acetylation level was
detected by Western blot with anti-acetylated lysine antibody. As
shown in Fig. 1A, WRN acetylation is clearly detected with CBP
(lane 2) and p300 (lane 3) co-transfection, but not with PCAF,
MOF, and Tip60 co-transfection (lanes 4–6), indicating that CBP
and p300 are the major acetyltransferase for WRN acetylation.
We then purified acetylated WRN protein after co-transfection
of FLAG-tagged WRN with both CBP and p300. The protein was
digested with trypsin and analyzed by both MALDI-TOF and LC-
ESI MS/MS. A number of acetylated lysine containing peptides
were identified (Fig. 1B). The acetylated lysine residues in WRN
were K366, K887, K1117, K1127, K1389, and K1413.
Confirmation of WRN acetylation sites in cells
We used the in cell acetylation assay to confirm the WRN
acetylation sites identified by mass spectrometry analysis. Our
strategy was to mutate these putatively acetylated lysines to
arginines, since arginine can not be acetylated but retains the
positive charge. First, single mutations were made on all 6 lysines.
Single mutations of K1117R and K1389R showed significant
reductions in the overall level of WRN acetylation (Fig. 2A, lanes 4
and 6). Then, the double mutation constructs K1117/1127R and
K1389/1413R were constructed. Both double mutants showed
Figure 1. Identification of WRN acetylation sites. A, acetylation assay in cells with different acetyltransferases. Western blot analysis was
performed with anti-acetylated lysine antibody (Upper panel) or with anti-WRN antibody. The experiment was repeated at least two times. B, mass-
spectrometry analyses identify the WRN acetylation sites. Acetylated WRN protein was purified by co-transfection of FLAG-tagged WRN with both
CBP and p300. The protein was digested with trypsin and analyzed by both MALDI-TOF and LC-ESI MS/MS. Scores of ESI or MALDI QIT were shown.
Mascot scores greater than 40 or found in both MALDI and ESI were most confident for the true detection of acetylation.
doi:10.1371/journal.pone.0010341.g001
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decreased WRN acetylation (Fig. 2B, lanes 2 and 3). Furthermore,
upon expression of the triple mutant K1127/1389/1413R and
quadruple mutant K1117/1127/1389/1413R, both mutants
showed further decreased WRN acetylation level but weak
acetylation still can be detected (Fig. 2B, lanes 4 and 5). We
finally mutated all of these six lysines to arginines. WRN
acetylation was at the lowest level detected in this WRN-6KR
mutant (Fig. 2C, lane 6), indicating that all 6 lysines are subject to
WRN acetylation.
CBP stabilizes WRN while SIRT1 reverses this effect
When acetylation assays were performed, we always noticed
that co-transfection of WRN and CBP not only resulted in WRN
acetylation (Fig. 3A, lane 2, lower panel), but also led to a
significant increase in the level of WRN protein (Fig. 3A, lane 2 vs.
lane 1, upper panel). We further investigated whether CBP can
stabilize the endogenous WRN level by overexpressing CBP in
HEK293 cells; indeed, endogenous WRN was increased by CBP
overexpression (Fig. 3B, lane 2 vs. lane 1). We also down-regulated
CBP by RNAi and examined its effect on WRN. Our results show
that WRN protein level was slightly reduced after CBP
knockdown (Fig. 3C and D). Since CBP is also a transcriptional
co-activator, it is possible that CBP may increase WRN gene
expression. We examined the WRN RNA level by Real-time PCR
in HEK293 cells transfected with CBP or empty vector. When
RNA was isolated 12 hours after transfection, WRN mRNA levels
did not significantly change (Fig. 3E), indicating that the observed
increase in WRN protein is the result of a CBP-mediated
posttranslational event.
We previously found that the NAD-dependent histone deace-
tylase SIRT1 can specifically deacetylate WRN and regulate its
enzymatic activities and cellular localization [16]. Here, we also
examined if SIRT1 can reverse CBP stabilization of WRN. Flag-
WRN and SIRT1 (or vectors alone) were co-transfected into
HEK293 cells and the level of WRN was detected by Western
blotting. SIRT1 overexpression clearly decreases WRN protein
level (Fig. 4A, lane 2 vs. lane 1, upper panel). We further examined
endogenous WRN protein level by SIRT1 expression. As
Figure 2. Confirmation of WRN acetylation sites in cells using acetylation assay. A, WRN-WT or single mutant was transfected with CBP
into HEK293 cells. After immunoprecipitation with FLAG M2 beads, the IP products were subjected to SDS-PAGE and Western blotting with anti-
acetylated lysine and anti-WRN antibodies. B, WRN-WT or double mutant or triple mutant or quadruple mutant or 6KR mutant was transfected with
CBP into cells. The same assay described in A was performed. All the experiments were repeated at least three times. The bands of WRN proteins were
quantified by ImageJ software.
doi:10.1371/journal.pone.0010341.g002
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expected, overexpression of SIRT1 in cells also reduced the level
of endogenous WRN (Fig. 4B, lane 2 vs. lane 1, upper panel). We
then knocked down endogenous SIRT1 by RNAi in the cells
(Fig. 4C, lane 2, middle panel); endogenous WRN levels were
clearly increased (Fig. 4C, lane 2 vs. lane 1, upper panel). These
results indicate that WRN protein is stabilized through CBP-
mediated acetylation, and SIRT1 can reverse this effect by
deacetylation of WRN.
WRN acetylation mutant is unable to be stabilized by CBP
Our finding that CBP stabilizes WRN through acetylation has
been further examined by expressing WRN acetylation mutant in
cells. Vectors expressing FLAG-WRN-wt or FLAG-WRN-6KR
were co-transfected with empty vector, CBP- or SIRT1-expression
vector into HEK293 cells and the levels of WRN protein were
detected by Western blotting. As expected, CBP increases WRN-
wt levels, while SIRT1 reverses this effect (Fig. 5A, lanes 1–3,
upper panel). In contrast, CBP failed to increase the level of
mutant WRN-6KR protein (Fig. 5A, lane 5 vs. lane 4, upper
panel), while SIRT1 co-transfection only showed a slight decrease
in WRN-6KR protein levels (Fig. 5A, lane 6 vs. lane 4, upper
panel), indicating that the acetylation mutant abrogated the ability
of CBP to stabilize WRN. We further examined if CBP can affect
the half-life of WRN. Vector or CBP were transfected into
HEK293 cells. Cells were treated with cycloheximide for the
indicated time and the levels of endogenous WRN protein were
detected by Western blotting. CBP indeed increased the half-life of
endogenous WRN (Fig. 5B, lanes 5–8 vs. lanes 1–4, upper panel).
We then examined the effect of CBP on wild type WRN and
acetylation mutant 6KR. FLAG-WRN-wt or 6KR alone or with
CBP were transfected into HEK293 cells. The same assay was
performed to examine the half-life of WRN protein. CBP
increased the half-life of WRN-wt (Fig. 5C, lanes 5–8 vs. lanes
1–4, upper panel) but failed to increase that of WRN-6KR
(Fig. 5D, lanes 5–8 vs. lanes 1–4, upper panel). All these data
demonstrate that CBP stabilizes WRN protein through
acetylation.
Acetylation stabilizes WRN protein through inhibiting its
ubiquitination
WRN has been reported to be regulated by the ubiquitination
pathway [24]. We further examined if acetylation stabilizes WRN
protein by inhibiting its ubiquitination. FLAG-WRN alone or with
HA-Ub were transfected into HEK293 cells. After immunopre-
Figure 3. CBP stabilizes WRN protein. A, Flag-WRN alone or with CBP was transfected into HEK293 cells. After immunoprecipitation with FLAG
M2 beads, the IP products were subjected to SDS-PAGE and Western blotting with anti-WRN and anti-acetylated lysine antibodies. B, endogenous
WRN protein level was increased by CBP. Vector or CBP were transfected into HEK293 cells. Cell lysates were analyzed by Western blot with anti-WRN
and anti-b-actin antibodies. C, endogenous WRN protein level was decreased by CBP knockdown. HEK293 cells were transfected with siRNA for CBP
or GFP. Cell lysates were analyzed by Western blot with anti-WRN, anti-CBP, and anti-b-actin antibodies. D, WRN protein levels from C were
quantified. E, Vector or CBP was transfected into HEK293 cells. Total RNA was isolated and cDNA were synthesized using the Superscript III enzyme.
Real-time PCR was performed to detect the WRN mRNA level. All the experiments were repeated at least three times. The bands of WRN proteins
were quantified by ImageJ software.
doi:10.1371/journal.pone.0010341.g003
WRN Acetylation and Stability
PLoS ONE | www.plosone.org 4 April 2010 | Volume 5 | Issue 4 | e10341
cipitation with FLAG M2 beads, the IP products were subjected to
SDS-PAGE and Western blotting with anti-HA and anti-WRN
antibodies. WRN ubiquitination can be clearly detected (Fig. 6A,
lane 2 vs. lane 1) and is strongly enhanced by the proteasome
inhibitor MG132 (Fig. 6B, lane 5 vs. lane 3). The acetylation
mutant WRN-6KR was also examined by this ubiquitination
assay. FLAG-WRN-wt or –WRN-6KR was transfected with
vector or HA-Ub into HEK293 cells. WRN-6KR showed stronger
ubiquitination than WRN-wt (Fig. 6C, lane 5 vs. lane 3), indicating
that WRN acetylation and ubiquitination do not compete for the
same set of lysine residues.
The effect of CBP and SIRT1 on WRN ubiquitination was further
investigated. FLAG-WRN was co-transfected with vector, HA-Ub,
CBP and HA-Ub, or SIRT1 and HA-Ub into HEK293 cells. Co-
transfection of CBP clearly decreased WRN ubiquitination (Fig. 6D,
lane 4 vs. lane 3), while SIRT1 showed the opposite effect (Fig. 6D,
lane 5 vs. lane 4). These results suggest that CBP and SIRT1 regulate
WRN ubiquitination through acetylation/deacetylation.
WRN protein is acetylated and stabilized in response to
MMC
In order to explore the functional consequence of WRN
stabilization by acetylation, we treated cells with mitomycin C
(MMC), an agent that generates DNA interstrand crosslinks,
lesions that WRN function is thought to address [5]. MMC
treatment strongly induced WRN acetylation in cells that peaked
at one hour post-treatment (Fig. 7A, lane 2). As expected, WRN
protein was stabilized at this same time point (Fig. 7B, lane 2).
To further investigate whether WRN acetylation could affect
cellular response to MMC treatment, we generated three stable
transfectant cell lines. H1299 cells were infected with pBabe
control virus or virus encoding WRN-wt or WRN-6KR
containing lysine to arginine mutations at 6 lysine positions
(Fig. 1B) that mimics hypoacetylated WRN. WRN expression
levels for the latter two cell lines are similar (Fig. 8A). We also
examined both exonuclease and helicase activities for the purified
WRN-wt and WRN-6KR mutant. The WRN-6KR mutant
Figure 4. SIRT1 destabilizes WRN protein. A, Flag-WRN alone or with SIRT1 was transfected into HEK293 cells. Cell lysates were subjected to
SDS-PAGE and Western blotting with anti-WRN, anti-SIRT1 and anti-b-Actin antibodies. B, endogenous WRN protein level was decreased by SIRT1.
Vector or SIRT1 was transfected into HEK293 cells. Cell lysates were analyzed by Western blot with anti-WRN, anti-SIRT1, and anti-b-actin antibodies.
C, endogenous WRN protein level was increased by SIRT1 knockdown. HEK293 cells were transfected with siRNA for SIRT1 or GFP. Cell lysates were
analyzed by Western blot with anti-WRN, anti-SIRT1, and anti-b-actin antibodies. All the experiments were repeated at least three times. The bands of
WRN proteins were quantified by ImageJ software.
doi:10.1371/journal.pone.0010341.g004
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retains similar activities as the WRN-wt (Fig. 7C and D),
indicating that this mutant protein folds properly and also that
the 6 arginine substitutions do not significantly alter WRN’s
catalytic activities. MTT assay was carried out to detect cell
viability of these three WRN cell lines in response to MMC
treatment. As shown in Fig. 8B, expression of the WRN-6KR
mutant that mimics hypoacetylated WRN resulted in a less
efficient rescue of MMC treatment compared to WRN-wt. We
also examined colony formation of the three WRN stable lines
after MMC treatment. As shown in Fig. 8C, the number of
colonies from cells expressing WRN-6KR was significantly
reduced compared to WRN-wt cells in response to the same dose
of MMC. The vector control cells had the lowest survival rate in
both assays. These results indicate that the WRN-6KR acetylation
mutant partially impaired WRN function and suggest that
acetylation of WRN is physiologically important for cell survival
in response to MMC-induced DNA damage.
Discussion
Our previous study has demonstrated that WRN can be
acetylated in vivo, and WRN acetylation can regulate its enzymatic
activities and nuclear localization [16]. Here, we investigated
WRN acetylation in further depth, including how it regulates
WRN stability. We identified 6 lysines as major acetylation sites of
WRN protein by mass spectrometry analysis and acetylation
assays in cells. We further found that WRN acetylation can
regulate WRN protein stability by inhibiting its ubiquitination.
Importantly, WRN is strongly acetylated and stabilized in
response to mitomycin C treatment. H1299 cells stably expressing
WRN-6KR that mimics unacetylated WRN display significantly
higher MMC sensitivity compared with the cells stably expressing
wild-type WRN. These results demonstrate that WRN acetylation
plays significant physiological functions in response to DNA
damage.
The functions of WRN acetylation have been reported by
several groups. It was first reported by Blander and colleagues that
WRN acetylation is induced by DNA damage and is associated
with translocation from nucleoli to DNA damage foci [14]. Our
previous studies confirmed this result and further found that the
NAD-dependent histone deacetylase SIRT1 can deacetylate
WRN and also participate in the regulation of WRN translocation
[16]. Vaitiekunaite and colleagues also found that SIRT1 can
regulate WRN translocation [25]. In addition, we found that
WRN acetylation can influence its enzymatic activities [16].
Muftuoglu and colleagues also found that acetylation of WRN
altered its activity although their findings are somewhat different
[17], perhaps due to different DNA substrates or assay methods.
Figure 5. CBP stabilizes WRN protein through acetylation. A, WRN-WT or WRN-6KR were transfected with vector, CBP or SIRT1 into HEK293
cells. Cell lysates were analyzed by Western blot with anti-FLAG and anti-b-actin antibodies. WRN acetylation levels were detected by anti-acetylated
lysine antibody. B, CBP increased endogenous WRN half-life. Vector or CBP were transfected into HEK293 cells. Cells were treated with cycloheximide
for the indicated time. Cell lysates were analyzed by Western blot with anti-WRN and anti-b-actin antibodies. C, Flag-WRN-WT alone or with CBP was
transfected into HEK293 cells. Cells were treated with cycloheximide for the indicated time. Cell lysates were analyzed by Western blot with anti-FLAG
and anti-b-actin antibodies. D, CBP was unable to increase WRN-6KR half-life. Flag-WRN-6KR alone or with CBP was transfected into HEK293 cells.
Cells were treated with cycloheximide for the indicated time. Cell lysates were analyzed by Western blot with anti-FLAG and anti-b-actin antibodies.
All the experiments were repeated at least three times. The bands of WRN proteins were quantified by ImageJ software.
doi:10.1371/journal.pone.0010341.g005
WRN Acetylation and Stability
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Nevertheless, the results indicate that WRN enzymatic activities
can be regulated by acetylation in response to DNA damage.
WRN acetylation also is suggested to play an important role in
regulating base excision DNA repair [17]. In this study, we found
that acetylation can stabilize WRN protein through inhibiting its
ubiquitination and acetylation of WRN is important for cell
survival in response to MMC treatment. These findings contribute
significantly to our understanding of how WRN acetylation
regulates its functions. With our complete identification of the
WRN acetylation sites and production of acetylation mutants,
more physiological roles of WRN acetylation will be revealed.
We consistently observe that WRN protein levels increase when
we co-transfected WRN with CBP/p300 compared with WRN
alone. Since there is no obvious change in WRN mRNA levels
(Fig. 3C), this increased WRN level does not occur through
transcription activation. CBP/p300 has been reported to regulate
Figure 6. WRN acetylation inhibits its ubiquitination. A, Flag-WRN alone or with HA-ub was transfected into HEK293 cells. After
immunoprecipitation with FLAG M2 beads, the IP products were subjected to SDS-PAGE and Western blot with anti-HA and anti-WRN antibodies. B,
Flag-WRN alone or with HA-ub was transfected into HEK293 cells. Cells were treated with or without MG132 (5 mM, 8 hr). The same assay described in
A was performed. C, FLAG-WRN-WT or 6KR was transfected with vector, HA-ub into HEK293 cells. The same assay described in A was performed. D,
FLAG-WRN was transfected with vector, HA-ub, CBP and HA-ub, or SIRT1 and HA-ub into HEK293 cells. The same assay described in A was performed.
All the experiments were repeated at least three times.
doi:10.1371/journal.pone.0010341.g006
WRN Acetylation and Stability
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the stability of several proteins through acetylation, apparently by
inhibiting ubiquitination of the proteins. However, the precise
mechanisms could be different. Acetylation-mediated stabilization of
Smad7 is through competition between acetylation and ubiquitina-
tion of the same lysine residues—i.e., acetylation of these residues
prevented subsequent ubiquitination [23]. The same competitive
mechanism was reported for acetylation of SREBP1a [19]. On the
other hand, acetylation of the p53 C-terminal domain is sufficient to
affect its ubiquitination by mdm2 elsewhere on the protein. This
indicates that p53 acetylation regulates its ubiquitination through
other mechanisms in addition to the site competition [18]. Our
results demonstrating an increased amount of ubiquitination in
WRN-6KR acetylation mutant (Fig. 6C) supports the notion that
acetylation can protect a protein from ubiquitination by other means
than direct competition for modification sites. It is of note that
PCAF, another acetyltransferase, has also been reported to stabilize
E2F1 [22] and b-Catenin [21] through acetylation. Our results
show, however, that PCAF is unable to acetylate WRN (Fig. 1A).
Our previous findings showed that SIRT1 can deacetylate
WRN and also participate in the regulation of WRN translocation
and enzymatic activities [16]. In this study, we examined the role
of SIRT1 in the regulation of WRN stability. Overexpression of
SIRT1 in cells decreases WRN protein levels, while down
regulating SIRT1 by RNAi in cells can increase the WRN level
(Fig. 4). Consistent with these findings and those detailed above,
co-transfection of SIRT1 with WRN in cells increased the WRN
ubiquitination level (Fig. 6D). Our findings seem to be at odds with
the results recently reported by Kahyo and colleagues, who found
that the sirtuin-mediated deacetylation pathway stabilizes WRN
protein. However, their assay uses the SIRT1 inhibitor Sirtinol for
treating cells to detect WRN protein levels, without showing WRN
acetylation and SIRT1-mediated WRN deacetylation. Thus, it is
possible that treating cells with Sirtinol decreased WRN protein
levels through other mechanisms. Nevertheless, our results
showing that SIRT1 down-regulates WRN protein levels are also
supported by recent report by Vaitiekunaite and colleagues, who
found that increased SIRT1 expression in cells was associated with
down-regulation of endogenous WRN protein levels [25].
WRN is a multi-functional protein potentially involved in many
processes in DNA metabolism [26]. How WRN protein is
Figure 7. WRN is acetylated and stabilized in response to MMC treatment. A, HEK293 cells were treated with 0.5 mg/ml MMC for indicated
time. Cell lysates were immunoprecipitated by anti-acetylated WRN-K1389 antibody and western blotted by anti-WRN antibody (upper panel).
Portions of the cell lysates were western blotted by anti-WRN antibody to determine the equal amount of WRN protein in lysates for anti-acetylated
WRN antibody immunoprecipitation shown in upper panel. B, HEK293 cells were treated with 0.5 mg/ml MMC for indicated time. Equal amounts of
total protein were loaded on each lane and western blotted by anti-WRN antibody to determine the WRN amount (upper panel). Anti-b-Actin blot
was used as loading control (lower panel). C, Equal amounts of purified WRN-wt and WRN-6KR mutant were assayed for exonuclease activity on a
two-stranded fork substrate as described in Methods and DNA products were analyzed after denaturing PAGE. D, Equal and increasing amounts of
purified WRN-wt and WRN-6KR mutant proteins were assayed for helicase activity on a two-stranded fork and the products analyzed by native PAGE
as described in Methods. All the experiments were repeated at least two times.
doi:10.1371/journal.pone.0010341.g007
WRN Acetylation and Stability
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regulated in response to DNA damage is of great interest. Our
findings that acetylation of WRN stabilizes the protein through
inhibiting its ubiquitination and optimizes the response to MMC
treatment advanced our understanding of WRN regulation
following DNA damage. The exact mechanism of how WRN
acetylation prevents its ubiquitination remains unclear. It seems
probable that acetylation of WRN induces a conformational
change to prevent its ubiquitination. It is also possible that
acetylation of specific lysines in WRN can influence its interaction
with other proteins or DNA, that in turn masks other lysines from
ubiquitination. Further work is needed to understand the
molecular details of these events.
Materials and Methods
Culture medium and reagents
HEK293 and H1299 cells were obtained from American Type
Culture Collection and cultured in Dulbecco’s modified Eagle’s
medium supplemented with 10% fetal bovine serum. Anti-WRN
antibody (H300) was purchased from Santa Cruz Biotechnology
(Santa Cruz, CA). Anti-b-actin monoclonal antibody was
purchased from Sigma. Anti-acetylated-lysine antibody was
purchased from Cell Signaling Technology (Danvers, MA). Anti-
HA antibody (12CA5) was purchased from Roche. Transfection of
the SIRT1 siRNA (Dharmacon Inc.) was performed using
Oligofectamine reagent (Invitrogen) following the manufacturer’s
instructions with a final oligonucleotide concentration of 20 mM.
Immunoprecipitation and Detection of WRN acetylation
in cells
Immunoprecipitation and acetylation assays were as described
previously [27]. Briefly, HEK293 cells were transfected with
FLAG-WRN alone, or with CBP-containing plasmid DNA by the
calcium phosphate method. 36 h after transfection, cells were
harvested and lysed in FLAG lysis buffer (50 mM Tris, 137 mM
NaCl, 1 mM NaF, 1 mM NaVO3, 1% Triton X-100 and 0.2%
Sarkosyl, 1 mMDTT, 10% glycerol, pH 7.8) containing fresh
protease inhibitors, PMSF, 10 mM TSA and 5 mM nicotinamide.
Cell extracts were immunoprecipitated with anti-Flag monoclonal
antibody M2 beads (Sigma). After elution with the FLAG peptide,
the proteins were resolved by 8% SDS-PAGE gels and analyzed
by Western blotting with anti-acetylated Lysine or anti-WRN
antibodies.
Real-time PCR
Vector or CBP-containing plasmid DNAs were transfected into
HEK293 cells. 12 h after transfection, RNA was isolated using
Rneasy (Qiagen, Valencia CA). cDNA were synthesized using the
Superscript III enzyme (Invitrogen). Quantitative real-time PCR
Figure 8. WRN acetylation helps cell survival in response to MMC treatment. A, cells from three virus infected stable cell lines H1299/vector
(lane 1), H1299/Flag-WRN-WT (lane 2) and H1299/Flag-WRN-6KR (lane3) were lysed and immunoprecipitated by anti-Flag M2 beads. WRN protein
expression levels were determined by western blot with anti-WRN antibody. B, cells from three stable cell lines were treated with increasing doses of
MMC for 1 hr, followed by 48 h recovery. MTT assays were performed as detailed under ‘‘Materials and Methods’’. C, cells from three stable cell lines
were treated with increasing doses of MMC for 1 hr, and then allowed to grow for about 2 weeks. The formed colonies were fixed in ice-cold
methanol and stained with 0.5% crystal violet solution. The formed colonies were counted. All the experiments were repeated at least three times.
doi:10.1371/journal.pone.0010341.g008
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analysis was performed using SYBR green reagent (Invitrogen) on
a DNA engine opticon 2 cycler (Bio-rad laboratories, Hercules
CA). The following primers were used: WRN- Forward, GGA
TCA GCA CAG TCA GAA AAT GTT CT; WRN-Reverse,
GGA TAG ATT CAG TTT CCT AAG TTC ACC; HPRT-
Forward, ATC AGA CTG AAG AGC TAT TGT AAT GA;
HPRT-Reverse, TGG CTT ATA TCC AAC ACT TCG TG.
Ubiquitination assay
FLAG-WRN alone or with HA-Ub was transfected into
HEK293 cells. 36 h after transfection, cells were harvested and
lysed in FLAG lysis buffer (50 mM Tris, 137 mM NaCl, 1 mM
NaF, 1 mM NaVO3, 1% Triton X-100 and 0.2% Sarkosyl,
1 mMDTT, 10% glycerol, pH 7.8) containing fresh protease
inhibitors and PMSF. Cell extracts were immunoprecipitated with
anti-FLAG monoclonal antibody M2 beads (Sigma). After elution
with 20 ml 26SDS loading buffer, proteins were resolved by SDS-
PAGE and analyzed by Western blotting with anti-HA antibody to
detect ubiquitination, and anti-WRN antibody to detect WRN
protein level.
Measuring the half-life of WRN protein
FLAG-WRN alone or with CBP was transfected into HEK293
cells. 12 h after transfection, cells were washed with PBS, and
seeded into 60-mm dishes to normalize for the efficiency of the
transfection. On the next day, the cells were treated with
cycloheximide (100 mg/ml) for indicated time. Cells were
harvested and lysed in 100 ml RIPA buffer (10 mM Tris,
150 nM NaCl, 1% DOC, 0.05% SDS, 1% Triton X-100,
pH 8.0). Equal amounts of protein were separated by SDS-PAGE
and analyzed by Western blotting with anti-WRN antibody and
anti-b-actin antibody as a loading control.
MTT assay
Cells were seeded in 96-well plates, allowed to attach overnight,
then treated with increasing doses of MMC (0.1, 0.5, 1.0 mg/ml)
for 1 h and then incubated for another 48 h. Aliquots of 10 ml of
MTT (5 mg/ml) were added to each well. After 4 h, the color
formed was quantitated by a spectrophotometric plate reader
(Berkman, Inc) at 595 nm wavelength after solubilization in 100 ml
of DMSO.
Colony formation assay
Cells (1000 per 6 cm dish) were plated in triplicate. After
overnight attachment, cells were treated with three different
concentrations of MMC (0.1, 0.5, 1.0 mg/ml) for 1 h and then
allowed to grow for about 2 weeks. The formed colonies were fixed
in ice-cold methanol and stained with 0.5% crystal violet solution.
The formed colonies were counted.
Helicase and exonuclease assays
Helicase assays were performed on a two-stranded fork
substrate containing a 31 and 21 nt 59 and 39 single-stranded
arms, respectively. This substrate was generated by radiolabeling a
62-mer (59-CACTGACTCCAGGAACTGGAGGATGCCTAG-
GTGGCCAGCTGCCGTCCAG-ACTCAGAGGAGTG-39) with
[c-32P]-ATP and T4 polynucleotide kinase followed by annealing
with unlabeled, partially complementary 52-mer (59-CACTC-
CTCTGAGTCTGGACGGCAGCT- GGCCAAGTGTGAGT-
GTGAGTGTGAGT-39). Annealed substrate was gel-purified and
eluted into 10 mM Tris pH 8.0, 10 mM NaCl. FLAG-tagged
WRN-wt and WRN-6KR proteins were incubated with substrate
for 30 min at 37uC in 20 ml of WRN reaction buffer (40 mM Tris-
HCl, pH 8.0, 1 mM MgCl2, 250 mM ATP, 0.1% NP-40, 100 mg/
ml BSA, and 5 mM DTT). Reactions were subsequently
incubated with Proteinase K (1 mg/ml), SDS (0.2%) and EDTA
(5 mM) for 30 min at 37uC and then stopped by addition of one-
sixth volume of loading dyes (30% glycerol, 0.25% bromphenol
blue, 0.25% xylene cyanol, and 50 mM EDTA). Samples were
subjected to native polyacrylamide (6%) gel electrophoresis
(PAGE) in 1X TBE buffer at 100 V for 3 h at room temperature.
Gels were vacuum-dried and radioactive DNA was visualized by
phosphorimaging. The WRN exonuclease assay utilized a similar
two-stranded fork substrate (containing 31 and 21 nt 59 and 39
single-stranded arms, respectively), constructed by annealing the
labeled 62-mer (as above) to an unlabeled 52-mer (59-TCACTT-
GACAAGTGACTGTGAC- CTAGGCATCCTCCAGTTCCT-
GGAGTCAGTG-39) then purified as above. WRN-wt and
WRN-6KR proteins were preincubated on ice for 5 min in
10 ml of WRN reaction buffer (including 1 mM MnCl2 instead of
MgCl2), and then transferred to 37uC for 20 min. Reactions were
stopped by addition of formamide loading buffer (95% formamide,
20 mM EDTA, 0.1% bromphenol blue, and 0.1% xylene cyanol),
heated at 90uC and the DNA products separated by denaturing
(8%) PAGE. After gel drying, digestion of the labeled strand by the
39 to 59 exonuclease activity of WRN proteins was visualized by
phosphorimaging.
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